Early Stage Researcher at the Institute and Outpatient Clinic for Occupational, Social and Environmental Medicine
Klinikum der Universität München
Telefon: +49 89 4400 52358
The main objective of my PhD research is to study the occupational and environmental transmission of antibiotic resistance due to exposure to bacteria found in Waste Water Treatment Plants (WWTP). Specific aims include (1) to assess carriage of bacterial resistance genes in WWTP workers, in residents living in close proximity to the plants, and in water and air samples; (2) to generate dose-response and geo-spatial exposure models for carriage of resistance genes as affected by proximity to WWTP as point source. Our results will critically improve the current body of knowledge available concerning antibiotic resistance, and will allow formulation of effective measures against it.
Prof. Dr. Katja Radon
2017 - presentPh.D. candidate in Medical Research: Epidemiology & Public Health, LMU Munich, Germany
2014 - 2016 Master of Science Epidemiology, LMU Munich, Germany
2004 - 2010 Medical degree. University of Zulia – Maracaibo, Venezuela
2017 - presentDoctoral Candidate. at the Institute and Outpatient Clinic for Occupational,
Social and Environmental Medicine. LMU Munich, Germany
2014 - presentTutor (e-Learning). Master Occupational Safety and Health. Institute and Outpatient Clinic
for Occupational,Social and Environmental Medicine. LMU Munich, Germany
2011 - 2014 Emergency department physician. Clínica Falcón, S.A. - Maracaibo, Venezuela
2011 - 2014 Occupational Physician. Global Salud, C.A. - Maracaibo, Venezuela
2010 - 2011 Rural Physician. Hospital “San Roque”- Pregonero, Venezuela
Rodríguez-Molina D, Barth S, Herrera R, Rossmann C, Radon K, & Karnowski V. (2017, March 9). An educational intervention to improve knowledge about prevention against occupational asthma and allergies using targeted maximum likelihood estimation. Zenodo. http://doi.org/10.5281/zenodo.376116
Rojas E, Rodríguez-Molina D, Bolli P, Israili ZH, Faría J, Fidilio E, Bermúdez V, Velasco M. The role of adiponectin in endothelial dysfunction and hypertension. Current hypertension reports. 2014 Aug 1;16(8):1-8.
Hartman I, Rojas E, Rodríguez-Molina D. Incretin-based therapy for type 2 diabetes mellitus: pancreatic and extrapancreatic effects. American journal of therapeutics. 2013 Jul 1;20(4):384-93.
Bermúdez VJ, Rojas E, Toledo A, Rodríguez-Molina D, Vega K, Suárez L, Pacheco M, Canelón R, Arráiz N, Rojas J, Velasco M. Single-nucleotide polymorphisms in adiponectin, AdipoR1, and AdipoR2 genes: insulin resistance and type 2 diabetes mellitus candidate genes. American journal of therapeutics. 2013 Jul 1;20(4):414-21.